“FiteBac®” is a versatile antimicrobial technology, developed by Dr. Kirk Kimmerling and Dr. Franklin Tay, in collaboration with researchers from around the world, allowing for the incorporation of antimicrobial protection into almost any material. 

By linking potent quaternary ammonium antimicrobials to a polymerizable silane backbone, they have developed a versatile new class of antimicrobial compounds which can be permanently incorporated into most materials, including those used in modern dentistry.

Peer-reviewed scientific publications, as well as the recent clearance of K18 QAMS by the FDA for use in the manufacture of dental acrylics, shows the efficacy of the FiteBac® approach.

FiteBac® Dental, LLC has the exclusive worldwide rights to develop and commercialize FiteBac® technology for use in dental applications.